-+ 0.00%
-+ 0.00%
-+ 0.00%

There May Be Reason For Hope In KYORIN Pharmaceutical's (TSE:4569) Disappointing Earnings

Simply Wall St·11/18/2026 22:48:39
Listen to the news

Shareholders appeared unconcerned with KYORIN Pharmaceutical Co., Ltd.'s (TSE:4569) lackluster earnings report last week. We did some digging, and we believe the earnings are stronger than they seem.

earnings-and-revenue-history
TSE:4569 Earnings and Revenue History November 18th 2026

The Impact Of Unusual Items On Profit

For anyone who wants to understand KYORIN Pharmaceutical's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit was reduced by JP¥2.6b due to unusual items. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And, after all, that's exactly what the accounting terminology implies. KYORIN Pharmaceutical took a rather significant hit from unusual items in the year to September 2026. All else being equal, this would likely have the effect of making the statutory profit look worse than its underlying earnings power.

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

Our Take On KYORIN Pharmaceutical's Profit Performance

As we discussed above, we think the significant unusual expense will make KYORIN Pharmaceutical's statutory profit lower than it would otherwise have been. Because of this, we think KYORIN Pharmaceutical's underlying earnings potential is as good as, or possibly even better, than the statutory profit makes it seem! Unfortunately, though, its earnings per share actually fell back over the last year. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. If you want to do dive deeper into KYORIN Pharmaceutical, you'd also look into what risks it is currently facing. You'd be interested to know, that we found 3 warning signs for KYORIN Pharmaceutical and you'll want to know about them.

Today we've zoomed in on a single data point to better understand the nature of KYORIN Pharmaceutical's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.